Odyssey Thera Inc.
Records under this name other than patents Odyssey Thera Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,101,364 | Fragments of fluorescent proteins for protein fragment complementation assays Lapsed on the fee record Ended Jan 24, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 24, 2020 | USPTO record |
| US 7,989,218 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Lapsed on the fee record Ended Aug 2, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 2, 2019 | USPTO record |
| US 7,306,914 | Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy Term ended Term ended Dec 7, 2018 · USPTO record | Term ended | Term ended Dec 7, 2018 | USPTO record |
| US 7,160,691 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Term ended Oct 14, 2018 · USPTO record | Term ended | Term ended Oct 14, 2018 | USPTO record |
| US 6,294,330 | Protein fragment complementation assays for the detection of biological or drug interactions Term ended Term ended Jul 30, 2018 · USPTO record | Term ended | Term ended Jul 30, 2018 | USPTO record |
| US 6,270,964 | Protein fragment complementation assays for the detection of biological or drug interactions Term ended Term ended Feb 2, 2018 · USPTO record | Term ended | Term ended Feb 2, 2018 | USPTO record |
| US 6,428,951 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Ended no later than Feb 2, 2018 · USPTO record | Term ended | Ended no later than Feb 2, 2018 | USPTO record |
| US 7,166,424 | Fragments of fluorescent proteins for protein fragment complementation assays Term ended Term ended Feb 2, 2018 · USPTO record | Term ended | Term ended Feb 2, 2018 | USPTO record |
| US 8,192,944 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Ended no later than Feb 2, 2018 · USPTO record | Term ended | Ended no later than Feb 2, 2018 | USPTO record |
| US 7,625,700 | In vivo library-versus-library selection of optimized protein-protein interactions Lapsed on the fee record Ended Dec 1, 2017 · USPTO record | Lapsed on the fee record | Ended Dec 1, 2017 | USPTO record |